3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
66
Lymphoma, Follicular
21
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Mantle-Cell
10
Lymphoma
10
Recurrence
7
Lymphoma, B-Cell, Marginal Zone
7
Neoplasms, Plasma Cell
6
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Smoldering Multiple Myeloma
3
Neoplasms
3
Neuroblastoma
2
Neoplasm, Residual
2
Myelodysplastic Syndromes
2
Leukemia, Plasma Cell
2
Leukemia, Myelomonocytic, Chronic
2
Hematologic Diseases
2
Burkitt Lymphoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Plasma Cell Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, B-Cell
1
Leukemia, Hairy Cell
1
Leukemia
1
Interventions
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
ruxolitinib
1
ponatinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Tacrolimus
1
Quality of Life
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Electrocardiography
1
Cyclophosphamide
1
Clinical Laboratory Techniques
1
CPI-0610
1
Busulfan
1
Bone Marrow Transplantation
1
Bone Marrow Examination
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bone Marrow Diseases
×
Lenalidomide
×
90 days
×
Clear all
No trials found.